Skip to main content
. 2019 Dec 2;9:18021. doi: 10.1038/s41598-019-54226-7

Figure 2.

Figure 2

Concentrations of the three anti-VEGF biologics before and after storage in silicone oil-free plastic syringes. Undiluted and diluted (1:10) samples collected at day 0 (D0) shown in black, and day 7 (D7) shown in blue for (a) ranibizumab, (b) aflibercept and (c) bevacizumab. Measurements are presented as mean ± SD. For each sample set n = 6. The unpaired Student’s t-test was used for statistical analysis.